DK1219301T3 - Vacciner, som indeholder hybridpolypeptider, der består af mindst to forskellige allergene proteiner - Google Patents

Vacciner, som indeholder hybridpolypeptider, der består af mindst to forskellige allergene proteiner

Info

Publication number
DK1219301T3
DK1219301T3 DK01130292T DK01130292T DK1219301T3 DK 1219301 T3 DK1219301 T3 DK 1219301T3 DK 01130292 T DK01130292 T DK 01130292T DK 01130292 T DK01130292 T DK 01130292T DK 1219301 T3 DK1219301 T3 DK 1219301T3
Authority
DK
Denmark
Prior art keywords
hybrid polypeptides
allergenic proteins
vaccines containing
polypeptides consisting
containing hybrid
Prior art date
Application number
DK01130292T
Other languages
Danish (da)
English (en)
Inventor
Birgit Linhart
Dietrich Kraft
Rudolf Valenta
Original Assignee
Biomay Prod & Handel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170854&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1219301(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biomay Prod & Handel filed Critical Biomay Prod & Handel
Application granted granted Critical
Publication of DK1219301T3 publication Critical patent/DK1219301T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
DK01130292T 2000-12-28 2001-12-20 Vacciner, som indeholder hybridpolypeptider, der består af mindst to forskellige allergene proteiner DK1219301T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00128660A EP1221317A1 (de) 2000-12-28 2000-12-28 Impfstoffe, die hybride Polypeptide mit mindestens zwei verschiedenen Allergenen enthalten

Publications (1)

Publication Number Publication Date
DK1219301T3 true DK1219301T3 (da) 2007-10-22

Family

ID=8170854

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01130292T DK1219301T3 (da) 2000-12-28 2001-12-20 Vacciner, som indeholder hybridpolypeptider, der består af mindst to forskellige allergene proteiner

Country Status (8)

Country Link
US (2) US7862828B2 (de)
EP (2) EP1221317A1 (de)
AT (1) ATE367826T1 (de)
DE (1) DE60129528T2 (de)
DK (1) DK1219301T3 (de)
ES (1) ES2287067T3 (de)
HK (1) HK1046648B (de)
PT (1) PT1219301E (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8709435B2 (en) 2003-01-21 2014-04-29 Biomay Ag Hypallergenic mosaic antigens and methods of making same
DK1440979T3 (da) * 2003-01-21 2005-12-19 Biomay Prod & Handel Fremgangsmåde til fremstillingen af hypoallergene mosaikproteiner
ITRM20030247A1 (it) * 2003-05-20 2004-11-21 Bonura Angela Varianti ipoallergeniche degli allergeni maggiori
WO2005030249A1 (en) * 2003-09-30 2005-04-07 Telethon Institute For Child Health Research Immunotherapy method
DE10351471A1 (de) * 2003-11-04 2005-06-09 Ursula Prof. Dr. Wiedermann-Schmidt Polyvalente Allergievakzine
ES2424229T3 (es) * 2005-03-18 2013-09-30 Cytos Biotechnology Ag Proteínas de fusión de alérgenos de gato y utilización de las mismas
US20070065468A1 (en) * 2005-08-29 2007-03-22 National University Of Singapore Chimeric allergens for immunotherapy
ES2307381B1 (es) * 2006-04-12 2009-10-23 Bial Industrial Farmaceutica S.A. Proteinas quimericas hipoalergenicas pertenecientes a la familia de transportadoras de lipidos de parietaria judaica utiles para el tratami ento de alergias.
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
ES2638308T3 (es) 2008-03-25 2017-10-19 Bial Industrial Farmaceutica, S.A. Proteínas híbridas hipoalergénicas de alérgenos de ácaros del grupo 1 y 2 principales para uso en el tratamiento de alergias
EP2295076A1 (de) * 2009-09-10 2011-03-16 Biomay Ag Hypoallergene Hybridpolypeptide zur Allergiebehandlung
ITMI20112301A1 (it) * 2011-12-19 2013-06-20 Lofarma Spa Varianti ipoallergeniche dell'allergene maggiore phl p 5 di phleum pratense
WO2014045084A1 (es) 2012-09-20 2014-03-27 Universidad De Cartagena Proteínas de fusión con representación de diferentes alergenos: propuesta de vacuna para alergia a los ácaros

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116612A (en) * 1987-06-23 1992-05-26 Allergy Immuno Technologies, Inc. Immunotherapy agents for treatment of IgE mediated allergies
JP2596466B2 (ja) * 1990-03-03 1997-04-02 アサヒビール株式会社 ダニの主要アレルゲンの還伝情報を有するｄｎａおよび該アレルゲンの製造方法
US5736362A (en) * 1990-10-26 1998-04-07 The University Of Melbourne Ryegrass pollen allergen
NZ299122A (en) 1991-10-16 2005-02-25 Immulogic Pharma Corp Detecting and treating allergies using peptides with T-cell stimulating activity
US5820862A (en) * 1994-04-14 1998-10-13 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
SE9402089D0 (sv) * 1994-06-14 1994-06-14 Rudolf Valenta Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
GB9516293D0 (en) 1995-08-09 1995-10-11 Immunova Ltee Novel peptides and their use as vaccines
GB9516760D0 (en) * 1995-08-16 1995-10-18 Sandoz Ltd Organic compounds
US5804201A (en) * 1996-03-11 1998-09-08 The Rockefeller University Immunomodulatory peptides of vespid antigen 5

Also Published As

Publication number Publication date
DE60129528D1 (de) 2007-09-06
US7862828B2 (en) 2011-01-04
DE60129528T2 (de) 2008-04-10
ES2287067T3 (es) 2007-12-16
PT1219301E (pt) 2007-09-04
HK1046648B (zh) 2007-10-26
US20110150920A1 (en) 2011-06-23
EP1219301B1 (de) 2007-07-25
EP1221317A1 (de) 2002-07-10
HK1046648A1 (en) 2003-01-24
ATE367826T1 (de) 2007-08-15
US20020173625A1 (en) 2002-11-21
EP1219301A1 (de) 2002-07-03

Similar Documents

Publication Publication Date Title
TR200100056T2 (tr) Nörotrofik faktörler
DE60144145D1 (de) Subtilisin-variante
CY1114265T1 (el) Πρωτεϊνη συντηξης αλβουμινης
DK1219301T3 (da) Vacciner, som indeholder hybridpolypeptider, der består af mindst to forskellige allergene proteiner
HK1046016B (zh) 疫苗中的重組脫氧核糖核酸膠原
CY1113421T1 (el) Πυρηνικα οξεα και πολυπεπτιδια υποδοχεα
EA199900355A1 (ru) Теломераза обратная тринскриптаза
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
PT1090033E (pt) Particulas de proteinas de envelope do hcv: utilizacao para vacinacao
PE20020876A1 (es) Proteinas de fusion para la secrecion de una proteina de interes en sobrenadantes bacterianos
DE60030859D1 (de) Gruppen von borrelia burgdorferi, die lyme krankheit verursachen
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
BR0012919A (pt) Vacina para uso na profilaxia e/ou no tratamento da sìndrome de ponto branco (white spot syndrome) em crustáceos, proteìna estrutural derivada do vìrus da sìndrome de ponto branco, sequência de ácido nucléico, uso de uma proteìna estrutural, composição farmacêutica, anticorpos, vacina ou formulação farmacêutica, e, kit diagnóstico para detecção de wssv
EP1613345A4 (de) Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320
DE60118359D1 (de) Humanische pellino-polypeptide
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
SE9602822D0 (sv) New receptor
EA200400392A1 (ru) Связывающий каспазу-8 белок, его получение и применение
ATE414099T1 (de) Biologisch aktive peptide
DK1219299T3 (da) Allergivacciner og fremstilling deraf
DE69934953D1 (de) Impstoffe gegen Coccidiosis
DK0540560T3 (da) Ancrod-lignende proteiner, fremstilling og anvendelse deraf
PT524421E (pt) Herpesvirus humano tipo 6 proteina p 100, sequencias de adn correspondentes, preparacao e utilizacao
WO2001055209A3 (en) Novel human septin and uses thereof
SE9604439D0 (sv) New receptor